BTR Capital Management Inc. Decreases Holdings in CVS Health Corp (NYSE:CVS)

Punch & Assocs Investment owns 0.27% invested in CVS Health Corporation (NYSE:CVS) for 58,184 shares. Kiltearn Prtn Llp has 2.71% invested in CVS Health Corporation (NYSE:CVS) for 1.77 million shares. Wendell David Associates reported 11,982 shares. Norinchukin Financial Bank The has 313,280 shares for 0.22% of their portfolio. Focused Ltd Limited Liability Company owns 4.18% invested in CVS Health Corporation (NYSE:CVS) for 1.77 million shares. Ccm Advisers Limited Liability Corp owns 143,539 shares or 1.3% of their USA portfolio. 519,144 are owned by Royal London Asset Mgmt Ltd. Folger Nolan Fleming Douglas Capital Mgmt holds 0.07% or 8,450 shares. Ally Financial holds 105,000 shares. Uss Mgmt accumulated 45,827 shares or 0.03% of the stock. 6,100 are owned by First Wilshire Mngmt.

Since March 1, 2019, it had 6 insider purchases, and 0 insider sales for $1.68 million activity. Shares for $101,821 were bought by AGUIRRE FERNANDO on Monday, March 11. 4,000 shares were bought by LUDWIG EDWARD J, worth $233,080. CVS Health Corp has a one year low of $51.72 and a one year high of $82.15. Mizuho maintained CVS Health Corporation (NYSE:CVS) rating on Wednesday, February 27. The institutional investor owned 95,463 shares of the pharmacy operator's stock after selling 2,031 shares during the period. The institutional investor held 5,169 shares of the medical and nursing services company at the end of 2019Q1, valued at $279,000, down from 104,128 at the end of the previous reported quarter.

Several equities research analysts recently commented on CVS shares. The stock increased 0.61% or $0.34 during the last trading session, reaching $55.71. About 6.67 million shares traded.

Bank Of America Corp, which manages about $629.64B US Long portfolio, upped its stake in Ca Inc (NASDAQ:CA) by 21.93M shares to 22.00M shares, valued at $734.25M in 2019Q1, according to the filing. Meristem Family Wealth Limited Liability Company has invested 0.07% in CVS Health Corporation (NYSE:CVS). It has underperformed by 17.14% the S&P500. CVS's total short interest was 19.17M shares in August as published by FINRA.

CVS Health Corporation (NYSE:CVS) has declined 17.14% since August 5, 2018 and is downtrending. This is a 11.83% increase over earnings of $1.69 per share from the same period previous year. CVS's profit will be $2.19B for 8.02 P/E if the $1.70 EPS becomes a reality.

More notable recent CVS Health Corporation (NYSE:CVS) news were published by: which released: "CVS Pharmacy Expands CarePass Program Nationwide - PRNewswire" on August 05, 2019, also with their article: "CVS Stock Bears Have Got It All Wrong -" published on July 25, 2019, published: "Here’s What Hedge Funds Think About CVS Health Corporation (CVS) - Yahoo Finance" on June 10, 2019. Epoch Investment Partners Inc. raised its holdings in shares of CVS Health by 1,908.9% during the fourth quarter. "" on July 12, 2019.

The stock of Cvs Health Corporation (NYSE:CVS) registered an increase of 8.96% in short interest. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: and their article: "Why CVS Health Stock Lost 17% Through the First Half of 2019 - Motley Fool" published on July 15, 2019 as well as's news article titled: "Friday’s Vital Data: Bed Bath & Beyond, CVS and Merck -" with publication date: July 12, 2019. Therefore 88% are positive. Oppenheimer maintained the shares of CVS in report on Wednesday, February 20 with "Buy" rating. The rating was maintained by Robert W. Baird on Thursday, February 21 with "Hold". The firm has "Buy" rating by Mizuho given on Wednesday, February 20. Cantor Fitzgerald maintained CVS Health Corporation (NYSE:CVS) on Thursday, February 14 with "Buy" rating. The stock has an average rating of "Buy" and a consensus target price of $76.48. The stock of CVS Health Corporation (NYSE:CVS) earned "Buy" rating by SunTrust on Thursday, February 21. Citigroup maintained the stock with "Buy" rating in Wednesday, March 6 report. On Monday, April 29 the stock rating was maintained by Morgan Stanley with "Overweight". UBS maintained CVS Health Corporation (NYSE:CVS) on Thursday, May 2 with "Buy" rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.